POINT Biopharma Global Inc. (PNT) Reports Q3 Loss of $0.86/sh

POINT Biopharma Global Inc. (NASDAQ: PNT) reported Q3 EPS of ($0.86), versus ($0.75) reported last year. Revenue for the quarter came in at $869.7 thousand, versus $159.5 thousand reported last year.

For earnings history and earnings-related data on POINT Biopharma Global Inc. (PNT) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M